| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,208 |
14,821 |
$960K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,848 |
9,014 |
$724K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,833 |
7,804 |
$513K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,623 |
3,609 |
$326K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
5,744 |
5,386 |
$187K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,549 |
6,244 |
$137K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,732 |
4,879 |
$61K |
| 99000 |
|
5,467 |
4,916 |
$51K |
| 99215 |
Prolong outpt/office vis |
435 |
354 |
$42K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,527 |
4,357 |
$34K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
822 |
748 |
$33K |
| 71046 |
Radiologic examination, chest; 2 views |
1,577 |
1,530 |
$24K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,017 |
977 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,151 |
2,117 |
$23K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
572 |
559 |
$15K |
| 80305 |
|
2,119 |
1,601 |
$15K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
265 |
264 |
$14K |
| 87631 |
|
151 |
150 |
$14K |
| 81025 |
|
1,966 |
1,907 |
$11K |
| 81002 |
|
4,858 |
4,620 |
$11K |
| 74019 |
|
582 |
574 |
$10K |
| 87428 |
|
206 |
191 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
2,689 |
2,528 |
$6K |
| 99205 |
Prolong outpt/office vis |
49 |
49 |
$6K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
946 |
909 |
$4K |
| 87634 |
|
95 |
94 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
642 |
621 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,666 |
1,559 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
226 |
190 |
$2K |
| 72100 |
|
111 |
107 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
20 |
20 |
$2K |
| 73130 |
|
97 |
92 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
58 |
58 |
$2K |
| 93000 |
|
153 |
152 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
615 |
595 |
$835.51 |
| 73630 |
|
27 |
26 |
$448.80 |
| 80053 |
Comprehensive metabolic panel |
53 |
38 |
$279.68 |
| 99406 |
|
67 |
60 |
$255.60 |
| 69210 |
|
12 |
12 |
$249.57 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
414 |
398 |
$199.39 |
| 73560 |
|
12 |
12 |
$183.60 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
107 |
91 |
$171.92 |
| 86580 |
|
32 |
29 |
$165.78 |
| 99441 |
|
30 |
29 |
$158.40 |
| 82948 |
|
98 |
92 |
$134.35 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
35 |
31 |
$113.49 |
| 99001 |
|
523 |
460 |
$90.16 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
485 |
462 |
$31.89 |
| 99072 |
|
393 |
365 |
$21.75 |
| 99051 |
|
546 |
489 |
$7.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
114 |
112 |
$5.34 |
| 3008F |
|
195 |
188 |
$0.00 |
| 3079F |
|
13 |
13 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
13 |
13 |
$0.00 |
| 1000F |
|
45 |
45 |
$0.00 |
| 3074F |
|
174 |
167 |
$0.00 |
| 3075F |
|
14 |
14 |
$0.00 |
| 3078F |
|
169 |
165 |
$0.00 |